Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors

Behavioural Brain Research

Volumn 134, Issue 1-2, 2002, Pages 229-238

  Del Rosario, Capriles Nancy ^a   Pacchioni, Alejandra Maria ^a   Cancela, Liliana Marina ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Locomotor activity; Morphine; Naltrexone MK 801; Restraint stress; SCH23390; Sensitization; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALTREXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; SULPIRIDE; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG ANTAGONISM; IMMOBILIZATION STRESS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SENSITIZATION; TIME; ACUTE DISEASE; ANIMAL; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECT; EXERCISE; MENTAL STRESS; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MORPHINE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SULPIRIDE;

EID: 0037151275     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00038-4     Document Type: Article

References (69)

1. Differential effects of stressor in vivo dopamine release in striatum, nucleus accumbens and medial prefrontal cortex
2. The effect of housing and gender on morphine self-administration in rats
3. Interchangeability of stress and amphetamine in sensitization
4. Chronic restraint attenuates the immunosuppressive response induced by novel aversive stimuli
5. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine
6. Evidence of a complete independence of a neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine
7. D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation
8. Reduced apomorphine induced sedation following chronic stress
9. Chronic stress attenuation of α-adrenoceptor reactivity is reversed by naltrexone
10. Opioid involvement in the adaptive change of 5-HT1a receptors induced by chronic restraint
11. Effect of different restraint schedules on the immobility in the forced swim test: modulation by an opiate mechanism
12. Anxiolytic-like effect induced by chronic stress is reversed by naloxone pretreatment
13. Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N,N-dimethyltryptamine
14. 2 receptors
15. Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward
16. Increases locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers
17. Self-administration of psychoactive substances by the monkey
18. Repeated corticosterone administration sensitizes the locomotor response to amphetamine
19. Social isolation-induced enhancement of the psychomotor effects of morphine depends on corticosterone secretion
20. The determinants of stress-induced activation of the prefrontal cortical dopamine system
21. The nucleus accumbens core and shell: accumbal compartments and their functional attributes
22. 2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine
23. High-speed chronoamperometric measurements of mesolimbic and nigrostriatal dopamine release associated with repeated daily stress
24. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitization agents
25. Non-contingent electric footshock facilities the acquisition of intravenous cocaine self-administration in rats
26. Alterations of amphetamine elicited perseveration and locomotor excitation following acute and repeated stressor application
27. Repeated stress increases locomotor response to amphetamine
28. Self-injection of amphetamine directly into the brain
29. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats
30. Repeated stressful experiences differently affect limbic dopamine release during and following stress
31. Repeated stressful experiences differently affect the time-dependent responses of mesolimbic dopamine system to the stressor
32. MK-801 prevents the development of behavioral sensitization during repeated morphine administration
33. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization
34. Enkephalin release into ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine
35. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
36. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress
37. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior
38. Enhancement of some 5-HT-dependent behavioral responses following repeated immobilization in rats
39. The mesolimbic circuit in drug dependence and reward: a role for the extended amygdala
40. Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics
41. Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus accumbens amphetamine
42. Both glutamate receptors antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neurodaptations
43. Life events-induced decrease of corticosteroid type I receptors is associated with reduced corticosterone feedback and enhanced vulnerability to amphetamine self-administration
44. Coping and stress-induced potentiation of stimulant stereotypy in the rat
45. Activational effects of social stress on IV cocaine self-administration
46. Chronic variable stress enhances the stimulatory action of a low dose of morphine: reversal by desipramine
47. Neuroanatomical focus for morphine and enkephalin-induced hypermotility
48. Isolation rearing enhances the locomotor response to cocaine and a novel environment, but impairs the intravenous self-administration of cocaine
49. Stress-and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration
50. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
51. Intravenous cocaine, morphine, and amphetamine preferentially increases extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens
52. The enduring effects of prior stress on amphetamine-induced rotational behavior
53. The neural basis of drug craving: an incentive-sensitization theory of addiction
54. Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat
55. Effects of stress on oral morphine and fentanyl self-administration in rats
56. Temporal factors in the effect of restraint stress on morphine-induced behavioral sensitization in the rat
57. Stress and corticosteroid-induce modulation of the locomotor response to morphine in rats
58. Brain adrenergic receptors and resistance to stress
59. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex
60. Does dizolcipine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats?
61. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats
62. Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA
63. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine
64. A psychomotor stimulant theory of addiction
65. Brain dopamine and reward
66. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization
67. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonist